RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kim Kline to Cell Line, Tumor

This is a "connection" page, showing publications Kim Kline has written about Cell Line, Tumor.
Connection Strength

0.639
  1. Gopalan A, Yu W, Jiang Q, Jang Y, Sanders BG, Kline K. Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells. Mol Nutr Food Res. 2012 Dec; 56(12):1803-11.
    View in: PubMed
    Score: 0.058
  2. Xiong A, Yu W, Tiwary R, Sanders BG, Kline K. Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells. Mol Nutr Food Res. 2012 Jun; 56(6):923-34.
    View in: PubMed
    Score: 0.057
  3. Tiwary R, Yu W, deGraffenried LA, Sanders BG, Kline K. Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer. Breast Cancer Res. 2011; 13(6):R120.
    View in: PubMed
    Score: 0.055
  4. Tiwary R, Yu W, Sanders BG, Kline K. a-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73. Breast Cancer Res. 2011 Jan 07; 13(1):R1.
    View in: PubMed
    Score: 0.052
  5. Tiwary R, Yu W, Li J, Park SK, Sanders BG, Kline K. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis. PLoS One. 2010 Jul 29; 5(7):e11865.
    View in: PubMed
    Score: 0.050
  6. Park SK, Sanders BG, Kline K. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res Treat. 2010 Nov; 124(2):361-75.
    View in: PubMed
    Score: 0.049
  7. Wang P, Yu W, Hu Z, Jia L, Iyer VR, Sanders BG, Kline K. Involvement of JNK/p73/NOXA in vitamin E analog-induced apoptosis of human breast cancer cells. Mol Carcinog. 2008 Jun; 47(6):436-45.
    View in: PubMed
    Score: 0.043
  8. Jia L, Yu W, Wang P, Sanders BG, Kline K. In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells. Prostate. 2008 Jun 01; 68(8):849-60.
    View in: PubMed
    Score: 0.043
  9. Yu W, Jia L, Wang P, Lawson KA, Simmons-Menchaca M, Park SK, Sun L, Sanders BG, Kline K. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms. Mol Nutr Food Res. 2008 Apr; 52(4):447-56.
    View in: PubMed
    Score: 0.043
  10. Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Prostate. 2008 Mar 01; 68(4):427-41.
    View in: PubMed
    Score: 0.042
  11. Snyder RM, Yu W, Jia L, Sanders BG, Kline K. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth. Nutr Cancer. 2008; 60(3):401-11.
    View in: PubMed
    Score: 0.042
  12. Wang P, Jia L, Sanders BG, Kline K. Liposomal or nanoparticle alpha-TEA reduced 66cl-4 murine mammary cancer burden and metastasis. Drug Deliv. 2007 Nov; 14(8):497-505.
    View in: PubMed
    Score: 0.041
  13. Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA. Cancer Res. 2004 Jun 15; 64(12):4263-9.
    View in: PubMed
    Score: 0.033
  14. Shun MC, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG, Kline K. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer. 2004; 48(1):95-105.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support